CA992081A - Pyrido (3,2-d) pyrimidines - Google Patents

Pyrido (3,2-d) pyrimidines

Info

Publication number
CA992081A
CA992081A CA139,149A CA139149A CA992081A CA 992081 A CA992081 A CA 992081A CA 139149 A CA139149 A CA 139149A CA 992081 A CA992081 A CA 992081A
Authority
CA
Canada
Prior art keywords
pyrido
pyrimidines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA139,149A
Inventor
Berthold Narr
Josef Roch
Josef Nickl
Erich Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Dr Karl Thomae GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712117657 external-priority patent/DE2117657B2/en
Priority claimed from DE19722202367 external-priority patent/DE2202367A1/en
Priority claimed from DE19722208534 external-priority patent/DE2208534A1/en
Priority claimed from DE19722208535 external-priority patent/DE2208535A1/en
Application filed by Dr Karl Thomae GmbH filed Critical Dr Karl Thomae GmbH
Application granted granted Critical
Publication of CA992081A publication Critical patent/CA992081A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA139,149A 1971-04-10 1972-04-07 Pyrido (3,2-d) pyrimidines Expired CA992081A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19712117657 DE2117657B2 (en) 1971-04-10 1971-04-10 PYRIDO SQUARE BRACKET ON 3.2-ANGLE BRACKET FOR PYRIMIDINE
DE19722202367 DE2202367A1 (en) 1972-01-19 1972-01-19 Pyrido(3,2-d)pyrimidines - anticoagulants
DE19722208534 DE2208534A1 (en) 1972-02-23 1972-02-23 Pyrido(3,2-d)pyrimidines - anticoagulants
DE19722208535 DE2208535A1 (en) 1972-02-23 1972-02-23 Pyrido(3,2-d)pyrimidines - anticoagulants

Publications (1)

Publication Number Publication Date
CA992081A true CA992081A (en) 1976-06-29

Family

ID=27431239

Family Applications (1)

Application Number Title Priority Date Filing Date
CA139,149A Expired CA992081A (en) 1971-04-10 1972-04-07 Pyrido (3,2-d) pyrimidines

Country Status (8)

Country Link
BE (1) BE781900A (en)
CA (1) CA992081A (en)
DD (1) DD97204A5 (en)
GB (1) GB1382487A (en)
HU (1) HU164346B (en)
IE (1) IE36269B1 (en)
IL (1) IL39174A (en)
NL (1) NL7204783A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8912336D0 (en) * 1989-05-30 1989-07-12 Smithkline Beckman Intercredit Compounds

Also Published As

Publication number Publication date
NL7204783A (en) 1972-10-12
IE36269B1 (en) 1976-09-29
IL39174A (en) 1975-02-10
GB1382487A (en) 1975-02-05
HU164346B (en) 1974-01-28
DD97204A5 (en) 1973-04-20
BE781900A (en) 1972-10-10
IE36269L (en) 1972-10-10
IL39174A0 (en) 1972-06-28

Similar Documents

Publication Publication Date Title
AU466496B2 (en) Pyrimidine derivatives
AU477075B2 (en) PYRIDO [2,3-d] PYRIMIDINES
AU463873B2 (en) 1, 4-bis-ACYLPIPERAZINES
ZA722416B (en) Improvements relating to pyrido(3,2-d)pyrimidines
CA1010863A (en) 2-substitutedthio-s-triazolo(1,5a)pyrimidines
CA970373A (en) Pyrazolo (3,4-b) pyridine-5-carboxamides
AU4117772A (en) 2, 4-diamino-5-benzyl-pyrimidines
CA992081A (en) Pyrido (3,2-d) pyrimidines
AU468934B2 (en) 4 HPYRIDO 3, 2-d 1, 3, 2 DIOXAPHOSPHORINANES
CA967964A (en) 2,4-diamino-5-(3,4,5-triethoxybenzyl) pyrimidine
AU467963B2 (en) SUBSTITUTED PYRIDO [3,2-d] PYRIMIDINES
CA968800A (en) 6-(p-formylaminophenyl)-4,5-dihydropyridazone-(3)
CA835392A (en) 4,5,7,8,9,13b-hexahydro-thieno (3',2',3,4) pyrido (1,2-d) (1,4) benzodiazepin-8-ones
CA989833A (en) 8-d-ribitylpyrido (2,3-d)pyrimidines
CA838127A (en) 4,5,7,8,9,13b-hexahydro-thieno(2,3-c) pyrido(1,2-d)(1,4)benzodiazepin-8-ones
CA871720A (en) 5-substituted amino-6-chloro-1h-imidazo(4,5-b) pyrazin-2-ones
AU457397B2 (en) AMINOALKYLAMINOTHIENO [3, 2-d J PYRIMIDINES
CA976543A (en) 4,6,8(14)-triene-steroids
CA975378A (en) 5-hydoxymethyl-(1,3-dioxa-2-silacyclohexanes)
CA979901A (en) 1,2-dihydro-2-oxopyrimido (4,5-b) quinoxaline derivatives
AU468307B2 (en) 1, 2-biguanides
CA887650A (en) 2,7-diamino-6-arylpyrido(2,3) pyrimidine derivatives
CA973184A (en) Substituted 1h-pyrido(2,3-b) (1,4) thiazine-2(3h)-thiones
CA884895A (en) Thiazolo (3,2-a) pyrimidine derivatives
CA888729A (en) 4h-pyrido (1,2-a)pyrimidin-4-ones